This is because the Congressional Budget Office (CBO), Congresss official scorekeeper for proposed legislation, would incorporate the cost of coverage for these other uses into its baseline estimates for Medicare spending, which means that the incremental cost of changing the law to allow Medicare coverage for anti-obesity drugs would be lower than it would be without FDAs approval of these drugs for other uses
These include -linolenic acid (C 18:3), which is a precursor of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and linoleic acid (C 18:2), the precursor of arachidonic acid (AA) (220, 221)
For those seeking a natural approach, we also provide personalized plans focused on nutrition, exercise, and sustainable lifestyle changes to support long-term success
Tesamorelin is FDA-approved for HIV-associated lipodystrophy, but it is also used off-label in broader populations seeking improved body composition and metabolic health